See the Glossary for more terms.
New processes in the works will affect how you will complete and submit your progress reports.
You will benefit from eSNAP's less stringent rules.
Beginning with progress reports due August 1, 2010, you will submit SNAP progress reports electronically through the eRA Commons. This change does not affect non-SNAP progress reports.
Around July 23, NIH plans to automatically enable eSNAP for every institution and sometime this fall will remove the option to disable it.
Don't be concerned—you will benefit from eSNAP's less stringent rules, which allow the following:
For more details, read the May 7, 2010, Guide notice. To learn more about eSNAP, go to the eSNAP (Electronic Streamlined Noncompeting Award Process) SOP.
We have more information in Send Us an Annual Progress Report in the Strategy for NIH Funding and our Progress Reports and eSNAP and Managing a Grant questions and answers.
OMB's new form has mandatory, standard fields for all federal agency progress reports as well as optional fields that NIH may use to collect extra information.
Last month, the White House's Office of Management and Budget released a new electronic progress report for all federal grantees. See its April 21, 2010, memo, Policy on Research Performance Progress Report (PDF).
The new form has mandatory, standard fields for all federal progress reports as well as optional fields that NIH may use to collect extra information. For details, see National Science Foundation's Final Format Research Performance Progress Report (PDF).
Implementation at NIH
NIH is working on its implementation strategy and plans to use the new form for electronic progress reports. We will give you more information in a future article. For now, continue using the PHS 2590.
Here's the thinking: with a single form for all federal grants, you won't have to learn how to fill out a new form for each agency, and management processes will take less time.
Another benefit is that government executives can more easily compare science results across programs and agencies, which will help them plan initiatives and set priorities.
New dates affect some investigators who applied through continuous submission.
NIH recently issued a Guide notice that appears to redefine your eligibility to resubmit twice. But for most people, the dates have not changed—you may send a second resubmission if the original application was due before January 26, 2009.
However, new dates do affect some investigators who applied through continuous submission. If you used continuous submission, the original application's Council date determines your eligibility to resubmit twice.
For an application assigned to a Council before August 2009, you may resubmit twice. Otherwise, you get only one resubmission.
And you must submit your second resubmission by the appropriate due date in the third review cycle this year. For a list of deadlines by grant type, go to the April 15, 2010, Guide notice.
And in case you're wondering, the last possible date for resubmitting a second time is for AIDS applications on January 7, 2011, for standard receipt dates or February 7, 2011, for people eligible for continuous submission.
When we treat costs for genomic arrays as supplies, they make an outsize impact on F&A costs relative to the administrative burden they impose.
For applications submitted after May 12, 2010, NIH has a new policy for budgeting genomic arrays for high-throughput research in grant applications and contract proposals.
In each year of the project, your institution can include up to $75,000 for the purchase of genomic arrays in its F&A costs, after it meets a threshold of $50,000.
The new policy applies to new budget requests only—noncompeting awards are not affected.
NIH is taking this step due to a fairness issue. Investigators conducting research such as genome-wide association studies increasingly depend on these costly resources, which they usually buy from commercial sources through a simple purchase order.
When we treat these costs as supplies, they make an outsize impact on F&A costs relative to the administrative burden they impose.
Here's how the new calculation works.
For each year, include up to $75,000 of genomic array purchases in your F&A costs. For example, if you request $65,000 in year one and $250,000 in years two and three, your F&A base would include $65,000 in year one and $75,000 in the other two years.
We will review budget requests for genomic arrays to make sure they comply with the new policy. If a proposed budget does not comply, a grants management specialist will ask you for a revised budget and incorporate required changes into your Notice of Award.
Read the May 13, 2010, Guide notice for details.
Get direct access to NIAID's solicitation lists through FedBizOpps.
Though we used to post new contract solicitations on our NIAID Funding Opportunities List, now we're taking a better approach.
Our Contracts portal links directly to the FedBizOpps.gov site listings for NIAID:
This tack is better because you get access to solicitations, amendments, and award notices in one place, and you don't miss important changes published after a solicitation.
You can still Subscribe to Alerts for the R&D Contracts category to hear about new R&D solicitations by email. Or just watch the New Funding Opportunities section at the bottom of every issue of this newsletter.
Offerors: use the Worksheet as you prepare the Vertebrate Animal Section of your technical proposal.
Because the Vertebrate Animal Section is so important, NIH has created a Contract Proposal Vertebrate Animal Section Worksheet (PDF).
As an offeror, you can use the Worksheet to help you prepare your technical proposal.
During the technical evaluation, the scientific review group members rate your response to the five points outlined in Section L of the solicitation. If your proposal falls within the competitive range, you will need to address issues with this section during contract negotiations.
Read the April 19, 2010, Guide notice for more information on the new worksheet and explanation of offeror, review group, and NIH staff responsibilities.
We revised the Animal SOPs for Contracts to reflect the new details.
The Cycle delves into the ins and outs of grant planning, writing, and management and features advice from our in-house experts.
Competition for grants is tough, but help is right at your fingertips.
Gain insight into NIH's intricate workings so you can write a top-quality application with the Strategy for NIH Funding.
Each phase starts with a flowchart to illustrate key processes and decision points. From there you can access text for more in-depth information or go straight to our Table of Contents for the Strategy in the Strategy for NIH Funding for information on topics, such as:
In Application Tools, find other handy resources including the Advice Index of advice only, NIH Grant Cycle Checklists, and timelines, including R01 Planning to Award Timeline by Review Cycle.
Find answers to your most critical application questions, including:
For an introduction and tips to make the best use of the site, go to Start Here to Use the Strategy for NIH Funding in the Strategy for NIH Funding. And visit our All About Grants Tutorials portal to find more application tools and tutorials.
Get up to $500,000 annually for up to three years to discover chemical agents with novel mechanisms to kill mosquitoes or improve insecticide delivery and sustainability.
If you're interested in improving mosquito insecticides to stem the spread of malaria, take a look at the Grand Challenges: Insecticide Discovery Research Opportunity from the Foundation for the National Institutes of Health.
You can get up to $500,000 annually for up to three years to discover chemical agents with novel mechanisms to kill mosquitoes or improve insecticide delivery and sustainability.
For details, eligibility rules, and application and review procedures, read the Request for Proposals (PDF).
If you are interested in applying, send a letter of inquiry by 5:00 p.m. on June 25, 2010, through Grand Challenges in Global Health—VCTR.
Feel free to send us a question at email@example.com. After responding to you, we may include your question in the newsletter, incorporate it into the NIAID Research Funding site, or both.
NIH does not specify page limits for the different parts of the Research Strategy. You can put background material where appropriate, but make sure you include it in the Significance section.
For further information and help writing each section, read Strategy to Write the Research Plan, including Write the Research Strategy and Write the Research Strategy in the Strategy for NIH Funding.
Your authorized organizational representative at Yale should submit the application since you'll be a postdoc there when you apply. Enter Yale as the institution on your cover sheet.
In the application's resources available section, include information on your assistant professorship. Once you receive a fundable score and submit the phase II application, you'll provide the name of the institution where you will be a faculty member.
If you need guidance on writing your application, read Writing a Career Development Award Application in our Advice on Research Training and Career Awards. Also, make sure you know about Details of Career Development Application Changes (PDF).
Generally, fellowships do not have carryover authority, and NIAID does not usually allow carryover since we expect grantees to use all of the institutional allowance in the year that it was awarded. Grantees can always make a formal request, but there is no guarantee that we will approve it.
To find out how to request carryover, see our Carryover Requests SOP.
See these and older announcements at NIAID Funding Opportunities List.
back to top
Last Updated October 06, 2011
Last Reviewed May 26, 2010